Delivery Order SPE2DB25D3504-SPE2DB25FVUMS

Award Date 4/30/25
Potential Completion Date 5/1/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, AmerisourceBergen Drug Corp, for the delivery of 4560922501 - Cevimeline HCL 30 MG Capsule 100S. The firm-fixed-price, $2,371.91 delivery order has a completion date of May 15, 2023. AmerisourceBergen, a major pharmaceutical distributor, is providing these medical products to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,512.21, is for the delivery of 4566281332 CEVIMELINE HCL 30 MG CAPSULE 100S. The contract type is Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is October 31, 2024. This award is not designated as a set-aside. Amerisourcebergen holds...
The Defense Logistics Agency Troop Support Medical awarded a $122,760 delivery order to Amerisourcebergen Drug Corporation for 100 capsules of the pharmaceutical Cevimeline hydrochloride 30 mg. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DOD and other federal agencies. Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania by July 13, 2023. The firm fixed price...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $77,970 to Amerisourcebergen Drug Corporation to provide 100 capsules of the pharmaceutical Cevimeline hydrochloride. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order period of performance is June 26-27, 2023. As a major distributor of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will fulfill this order to supply the Defense...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,570.15 and an ultimate completion date of April 16, 2025. The contract is not set aside and allows for the delivery of a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications across various...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,213.44, is a firm fixed-price delivery order with a completion date of May 8, 2025. The contract is not set aside and allows for the delivery of a variety of pharmaceutical products and medical supplies to support federal medical procurement needs, particularly for military and veteran...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $504,108.28 and an ultimate completion date of November 6, 2023. The order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,508.13 and a performance period through May 2025. It is a firm fixed-price contract for the delivery of various pharmaceutical and medical products, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $42,920.32 and is for the delivery of a variety of pharmaceutical products and medical supplies to support military healthcare programs. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 8, 2025. The contract was not set aside for any...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract has a ceiling value of $592,772.43 and is a firm-fixed-price delivery order that will run through September 11, 2023. The contract is not set aside for any specific business type, indicating open competition. Amerisourcebergen Drug Corp, which is a subsidiary of the parent company Cencora, Inc., is a critical...
  • SPE2DB25D3504
    Indefinite Delivery Contract
  • SPE2DB25D3504-SPE2DB25FVUMS
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cevimeline HCL 30 mg capsules, with a firm fixed price of $1,038.61 and a period of performance through May 1, 2025. The contract is not set aside and was awarded on April 30, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is part of the company's broader role as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 7/30/25, 10:12 AM